I. INTRODUCTION
Stress-induced hyperglycemia is prevalent in the intensive care unit (ICU), occurring in patients even without prior diabetes [1] - [3] . Hyperglycaemia worsens outcomes, namely increasing the risk of severe infection, myocardial infarction, multiple organ failure and at worst, mortality [1] . Many studies [4] , [5] demonstrated that tight glucose control (TGC) may lessen ICU patients' mortality and other negative outcomes. A lot of TGC studies, either successful or unsuccessful had adopted nurse-implemented protocol that comes with some disadvantages: to name a few, as protocols are not individualized it is more of a one-size fits all method, some protocols may be ad-hoc or based on experience. Furthermore, providing round the clock care for ICU patients while adopting TGC has proven to be taxing.
One approach to develop a glycaemic control protocol that can be implemented within ICU is through model-based method. Model-based protocols deliver patient specific control where the control protocol can be devised individually. Through model-based methods, virtual trials may be simulated to design or develop protocols in-silico. Herewith attention to control glycaemia either through feed and/or insulin (subcutaneous, IV, bolus) may be evaluated and devised. Glycaemic control protocol may be optimized virtually to save time, money and most importantly to yield a better patient outcome.
SPRINT [4]
, a model-derived protocol was first implemented in Christchurch Hospital Department of Intensive Care in August 2005 and has treated over 1500 patients. SPRINT protocol has been effective at decreasing organ failure and mortality [6] , [7] giving the most secure control over all patients of several extensive studies [8], [9] . It modulates both nutrition and insulin to provide tight glycaemic control. Insulin and dietary inputs are taken into account on hourly or 2-hourly blood glucose (BG) measurements for TGC. The protocol specifies carbohydrate intake, formula and/or goal feed rates [10], [11] . SPRINT is a paper-based protocol, developed through extensive computer simulations and does not require a bed-side computer.
Stochastic Targeted protocol (STAR) [12] , downloadable on a tablet is a model-based protocol that uses a clinically validated glucose-insulin model which provides patient specific recommendations of insulin and nutrition while ensuring a 5% maximum risk of hypoglycaemia. STAR can be adopted over a scope of clinical scenarios and used for realtime bedside care. The adaptability of STAR includes to local nutrition practices, desired BG target levels, This study aims to assess, evaluate and compare the current clinical practice in a Malaysian ICU setting, Hospital Tengku Ampuan Afzan (HTAA) against SPRINT and STAR protocol performance using Malaysian critically-ill data. Both SPRINT and STAR protocols have managed to achieved BG band within 4.4-8.0 mmol/L at 93% and 86.6% respectively in clinical trials [12] . It would be interesting to see how Malaysian ICU patient that has been treated with intensive sliding-scale insulin infusion therapy fares against modelbased/model-derived protocol. Assessment and comparison of protocols are done through virtual trials, focusing on efficiency, safety and overall glycaemic control. Virtual trials provide the requirement to design the protocol in-silico by testing on virtual patient (actual patient data) to optimize protocol performance and safety without risk on actual patient. The simulation results would provide a basis of guideline if HTAA ICU would opt for a model-based/derived control protocol in future [14] .
II. METHODS

A. Patients Data
Virtual trials were performed on retrospective data of 91 critically ill patients treated under intensive sliding-scale insulin infusion at the ICU of HTAA. The socio-demographic characteristics and cohort details are summarized in Table 1 . Malay ethnicity makes the largest cohort at 89% and percentage of male patients is 54%. 69% of patients are under medical category and 63% of patients fall under age cohort of over 50 years old. The intensive insulin protocol used in HTAA to maintain BG concentration target was set at 5.1-8.0 mmol/L. The study was registered under the National Medical Research Register (NMR-13-1592-18706). Ethics was granted by IIUM Research Ethics Committee and National Institute of Health (NIH).
B. HTAA Sliding Scale Protocol
The flowchart in Figure 1 shows the intensive insulin infusion protocol adopted in the ICU of HTAA. BG target is between 5.1 mmol/L -8.0 mmol/L. Monitoring of BG is done hourly once insulin is administered and when there is no requirement of insulin rate change for 2 consecutive hours, BG is then measured 2 hourly. Frequency of monitoring is less once patient is considered stable. For detailed description of the protocol, refer to Figure 1 .
C. System Model
The glucose-insulin physiological model utilized as a part of this study is clinically-validated [15] . Known as ICING [15] model, it utilizes past and current BG values, past nutrition past insulin measurements to register the insulin sensitivity, SI of the patient over the previous time period, based on parameter identification algorithm [16] which fits the model to the clinically observed behavior.
D. SPRINT Protocol
SPRINT [6] protocol was implemented as a clinical practice change in intensive care unit of Christchurch Hospital in 2005. The entry criterion for the SPRINT protocol was a BG measurement of greater than 8 mmol/L on normal patient where 8 mmol/L represents higher glycaemic level. The BG measurement was taken hourly to ensure tight control and once patient is stable, two-hourly measurement is used. SPRINT will stop once patient is adequately selfregulating and stable for 6 or more hours with over 80% of the target feed [10], [11] . SPRINT has a lower and tighter BG target at 4.4-6.1 mmol/L.
E. STAR Protocol
The STAR (Stochastic Targeted) Figure 2 shows the steps of virtual trials starting from fitting, followed by simulation. The resulting time-varying SI profiles represent time-varying metabolic status for individual patients. This profile can be used to simulate the BG level for different insulin and dextrose inputs, associated with different control protocols. Thus, virtual trials present the closest view of possible behaviors seen typically in clinical setting. 
G. Analysis
The efficacy of SPRINT and STAR protocol on HTAA ICU patients is assessed in terms of performance and safety. A statistical Mann-Whitney U test was also done where a pvalue < 0.05 was considered to be significant. The explanation for this might lies under the cohort characteristics differences, particularly the SI. Figure 6 illustrates the CDF of SI In Figure 7 , it is illustrated that the distribution of SI over the 2 cohorts are significantly different. It is clear that SPRINT patients has a wider and flatter SI distribution. Patients in SPRINT has greater inter-patient variability whereas HTAA has less variability of SI. But even so, both SPRINT and STAR protocols with proven results in attaining higher BG median, higher percentage time in desired band, couldn't obtain the same level of percentage through virtual trials. Better glycaemic outcomes in terms of patients safety is clearly achieved in STAR protocol where percentage of BG>10 mmol/L is reduced by 29.3%. SPRINT protocol on the other hand reduced 16.6% of BG> 10 mmol/L. Higher percentage in reduction of mild hypoglycaemia is demonstrated by SPRINT protocol (BG<4.4 mmol/L) by 56% and STAR by 42%. Both SPRINT and STAR only had 1 patient with severe hypoglycaemia (BG<2.2 mmol/L), an 83% improvement. This supports the capability of SPRINT and STAR that firmly controls glycaemia particularly patients who are in danger of hypoglycaemia.
Control efficiency is associated with higher insulin inputs, and evident here as STAR protocol has the highest insulin rate at 6 U/hr, which is 4 Units higher than HTAA. Feeding is lower with 3.6 g/hr in STAR, 2 g/hr in SPRINT and 4.1 g/hr in HTAA. These results show that feed reduction is related to better glycaemic levels. Glycaemic control might be difficult to achieve with higher feeding rate but nutrition rules used in STAR still corresponds to 100% ACCP guidelines.
The key point seen here in these virtual trial results lies with the capacity of SPRINT and STAR in providing safe glycemic control is often challenging within ICU patients. This is something that is unique to model-based protocol as has been demonstrated and achieved by STAR protocol.
However there are many other area and issues that will be worthy to look at. For example, clinical integration that requires compliance of staff, differences in patient cohort (surgical, medical, cardio), diabetic status, differences in feed target practice etc. All these points when put into consideration might bring us to a different explanation to the virtual trials presented in this paper.
V. CONCLUSIONS
This study presented an analysis of clinical practice from an ICU in HTAA, simulated with SPRINT and STAR protocols. Through virtual simulations, patient's safety has been improved by 83% where only 1 patient had a severe case of hypoglycaemia. Overall, both SPRINT and STAR protocols have shown the ability in providing a safe and effective treatment. Thus, a model-based approach can safely be adopted and introduced into a Malaysian ICU settings 
